(PDF) Intravenous siRNA Silencing of Survivin Enhances

Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts

Journal of Urology - Netherlands

doi 10.1016/j.juro.2015.02.036

Full Text

Abstract

Available in full text

Categories

Date

July 1, 2015

Authors

Jessie L.-S. Au

M. Guillaume Wientjes

Michael A. O'Donnell

Kevin R. Loughlin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Silencing STAT3 With Short Hairpin RNA Enhances Radiosensitivity of Human Laryngeal Squamous Cell Carcinoma Xenografts in Vivo

Experimental and Therapeutic Medicine

Cancer Research

English

Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts

British Journal of Cancer

Cancer Research

English

Silencing of RTKN2 by siRNA Suppresses Proliferation, and Induces G1 Arrest and Apoptosis in Human Bladder Cancer Cells

Molecular Medicine Reports

Molecular Biology

Cancer Research

Molecular Medicine

English

Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells

Journal of Biological Chemistry

Molecular Biology

English

Effect of Photodynamic Therapy in Combination With Mitomycin C on a Mitomycin-Resistant Bladder Cancer Cell Line

British Journal of Cancer

Cancer Research

English

1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models

Cancer Research

English

Bipolar Transurethral Incision of Bladder Neck Stenoses With Mitomycin C Injection

Advances in Urology

English

Synthesis and Antitumor Activity of Macromolecular Derivatives of Mitomycin C.

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry

Organic Chemistry

English

The Pharmacokinetic Plasma Profile of Mitomycin C, Measured After Sequential Intermittent Intravenous Administration

European Journal of Cancer and Clinical Oncology

English